⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TCRX News
TScan Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
TCRX
TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation
globenewswire.com
TCRX
Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies
businesswire.com
TCRX
Form 8-K
sec.gov
TCRX
TailorCare Recognized as one of the Best Places to Work in Healthcare in 2026 for Two Years in a Row
globenewswire.com
TCRX
ThoroughCare Expands Remote Patient Monitoring with Withings Integration
businesswire.com
TCRX
Form 8-K
sec.gov
TCRX
TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TCRX
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
globenewswire.com
TCRX
TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
TCRX